-

Daniel Holzer joins UBS as Financial Advisor in Westport, CT

WESTPORT, Conn.--(BUSINESS WIRE)--UBS Global Wealth Management US today announced that Daniel Holzer has joined the firm as a Financial Advisor. Dan joins the UBS Westport, Connecticut office, which is managed by Market Director Jim Miller and is part of the Greater New York Market, led by Market Executive Mara Glassel.

“On behalf of UBS, we’re excited to welcome Dan to the firm,” said Jim Miller, Market Director at UBS Wealth Management. “His industry experience and dedication to his clients will be a great addition to our business, and we look forward to having him help us continue to expand our client offering in this key market.”

A dedicated financial advisor for his entire 29-year career, Dan joins UBS after a long tenure at Morgan Stanley. Known for his strong work ethic and deep expertise in structured products, Dan is passionate about delivering exceptional service and tailored solutions to his clients. He is especially excited to join UBS because of its unparalleled platform and reputation as the world’s leading global wealth manager.

Raised in Manhattan, Dan Holtzer attended Horace Mann School before earning his degree from the Johns Hopkins University. He and his wife, Barbara, now reside in Fairfield, Connecticut with their two sons.

Notes to Editors

About UBS

UBS is a leading and truly global wealth manager and the leading universal bank in Switzerland. It also provides diversified asset management solutions and focused investment banking capabilities. With the acquisition of Credit Suisse, UBS manages 6.9 trillion dollars of invested assets as per third quarter 2025. UBS helps clients achieve their financial goals through personalized advice, solutions and products. Headquartered in Zurich, Switzerland, the firm is operating in more than 50 markets around the globe. UBS Group shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).

https://www.ubs.com

© UBS 2025. All rights reserved. The key symbol and UBS are among the registered and unregistered trademarks of UBS. For press use only.

Contacts

Christina Aquilina
Christina.Aquilina@ubs.com

UBS

NYSE:UBS
Details
Headquarters: Zurich, Switzerland
CEO: Sergio Ermotti
Employees: 72,000
Organization: PUB

Release Versions

Contacts

Christina Aquilina
Christina.Aquilina@ubs.com

Social Media Profiles
More News From UBS

UBS Declares Quarterly Coupon Payment on Exchange Traded Note: AMUB

NEW YORK--(BUSINESS WIRE)--UBS Investment Bank today announced the coupon payment for the ETRACS Alerian MLP Index ETN Series B (NYSE Arca: “AMUB”), traded on the NYSE Arca. NYSE Ticker ETN Name and Prospectus Supplement* Coupon Valuation Date Ex-Date Record Date Payment Date Coupon Amount Payment Schedule Current Yield (annualized)** AMUB ETRACS Alerian MLP Index ETN Series B 8/17/26 8/28/26 8/28/26 9/8/26 $0.313 Quarterly 5.31% * The table above provides a hyperlink to the relevant prospectus...

UBS Hires Financial Advisor Brandon Burleigh in Hartford, CT

HARTFORD, Conn.--(BUSINESS WIRE)--UBS today announced that Financial Advisor Brandon Burleigh has joined the firm. Brandon joins UBS’s Hartford, Connecticut Office, managed by Gabriel D’Amica and part of the Greater New York Metro Market led by Mara Glassel. He joins Stone Harbor Group at UBS, a well-established team of five Financial Advisors. “Brandon brings a relationship-driven approach and a deep commitment to helping clients pursue their financial goals,” said Gabriel D’Amica, Market Dire...

UBS Announces Call Settlement Amounts for Seven ETNs

NEW YORK--(BUSINESS WIRE)--UBS AG announced today the per-security amounts payable (collectively, the “Call Settlement Amounts”) for the below seven UBS-issued exchange traded notes set forth in the following table (collectively, the “ETNs”). Table-1 ETN Ticker ETN Name and Prospectus Supplement [1] Call Settlement Amount CUSIP Call Settlement Date IWDL ETRACS 2x Leveraged US Value Factor TR ETN due February 9, 2051[2] $70.2470 90278V107 08/19/2026 IWFL ETRACS 2x Leveraged US Growth Factor TR E...
Back to Newsroom